MBIO
$0.89
Pre-MarketAs of Mar 17, 8:00 PM UTC
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases.
Intraday
Custom Range:to
No data available for this range. Intraday data may be limited by the exchange.